Anti-Ulcer Agents
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Onconic TherapeuticsKorea - Seoul
1 program1
coadministration of JP-1366 and aceclofenacPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Onconic Therapeuticscoadministration of JP-1366 and aceclofenac
Jeil PharmaceuticalCohort 1
Clinical Trials (2)
Total enrollment: 203 patients across 2 trials
Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian
Start: Mar 2021Est. completion: Mar 202188 patients
Phase 1Completed
Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of JP-1366 Oral Administration in Healthy Male Subjects
Start: Dec 2017Est. completion: Apr 2019115 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.